For media inquiries, please contact Matt Middleman at:



Date Title
Nov 16 Samumed Presents Data For Potential Topical Treatment for Psoriasis
Nov 15 Samumed's Wnt Pathway Modulator SM04690 Shows Potential as a Disease Modifying Treatment for Osteoarthrits (OA) of the Knee
Nov 15 Samumed Presents Data for a Small Molecule Modulator of the Wnt Pathway as a Potential Treatment for Degenerative Disc Disease
Nov 14 Samumed Presents Data for a Small Molecule Modulator of Wnt Pathway as a potential topical treatment for Chronic Tendinopathy
Nov 14 Samumed, LLC Presents Data for Small Molecule Modulator of Wnt Pathway as a Potential Topical Treatment for Scleroderma
Nov 01 Samumed Selected for Seven Presentations in Five Therapeutic Areas at American College of Rheumatology 2016 Annual Meeting
Oct 25 Samumed Successfully Completes a Phase II Androgenetic Alopecia (“AGA”) Biopsy Trial Studying Regeneration of Hair Follicles
Oct 13 Samumed's CEO Presents at the Forbes Healthcare Summit
Sep 17 Samumed’s CEO presents their regenerative medicine platform at the Royal Society of Medicine’s 13th Medical Innovations Summit
May 05 CNBC Interview with Samumed's CEO
Apr 13 Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging
Apr 13 The Forbes Global Game Changers List: Bezos, Zuckerberg And More Business Leaders Transforming The World
Apr 04 Samumed presents at the 2016 World Congress of the Osteoarthritis Research Society International (OARSI)
Mar 07 Samumed presents at the annual meeting of the American Academy of Dermatology (AAD) Safety and Efficacy results from its Phase 2 androgenetic alopecia (AGA) trial
Mar 05 Experimental Drug Shows Early Promise In Treating Male Baldness